Venous thromboembolism in multiple trauma patients

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Thromboembolic complications are frequent in patients with multiple trauma. The efficacy of unfractionated heparin for venous thrombosis prophylaxis has not been established. Based on limited prospective data, low- molecular-weight heparin appears to be more effective than unfractionated heparin and at least as effective as compression devices for preventing thromboembolic complications in these patients. Vena cava filters should be considered in high-risk patients who cannot receive anticoagulant therapy, but long-term filter use without concomitant anticoagulant therapy is associated with a substantial risk of recurrent thromboembolism.

Original languageEnglish (US)
Pages (from-to)1011-1023
Number of pages13
JournalPharmacotherapy
Volume18
Issue number5
StatePublished - Sep 1998

Fingerprint

Multiple Trauma
Venous Thromboembolism
Anticoagulants
Heparin
Vena Cava Filters
Low Molecular Weight Heparin
Thromboembolism
Venous Thrombosis
Equipment and Supplies
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Venous thromboembolism in multiple trauma patients. / Erstad, Brian L.

In: Pharmacotherapy, Vol. 18, No. 5, 09.1998, p. 1011-1023.

Research output: Contribution to journalArticle

@article{c75f7f0ae99c4e59b944e1d1f24c4059,
title = "Venous thromboembolism in multiple trauma patients",
abstract = "Thromboembolic complications are frequent in patients with multiple trauma. The efficacy of unfractionated heparin for venous thrombosis prophylaxis has not been established. Based on limited prospective data, low- molecular-weight heparin appears to be more effective than unfractionated heparin and at least as effective as compression devices for preventing thromboembolic complications in these patients. Vena cava filters should be considered in high-risk patients who cannot receive anticoagulant therapy, but long-term filter use without concomitant anticoagulant therapy is associated with a substantial risk of recurrent thromboembolism.",
author = "Erstad, {Brian L}",
year = "1998",
month = "9",
language = "English (US)",
volume = "18",
pages = "1011--1023",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Venous thromboembolism in multiple trauma patients

AU - Erstad, Brian L

PY - 1998/9

Y1 - 1998/9

N2 - Thromboembolic complications are frequent in patients with multiple trauma. The efficacy of unfractionated heparin for venous thrombosis prophylaxis has not been established. Based on limited prospective data, low- molecular-weight heparin appears to be more effective than unfractionated heparin and at least as effective as compression devices for preventing thromboembolic complications in these patients. Vena cava filters should be considered in high-risk patients who cannot receive anticoagulant therapy, but long-term filter use without concomitant anticoagulant therapy is associated with a substantial risk of recurrent thromboembolism.

AB - Thromboembolic complications are frequent in patients with multiple trauma. The efficacy of unfractionated heparin for venous thrombosis prophylaxis has not been established. Based on limited prospective data, low- molecular-weight heparin appears to be more effective than unfractionated heparin and at least as effective as compression devices for preventing thromboembolic complications in these patients. Vena cava filters should be considered in high-risk patients who cannot receive anticoagulant therapy, but long-term filter use without concomitant anticoagulant therapy is associated with a substantial risk of recurrent thromboembolism.

UR - http://www.scopus.com/inward/record.url?scp=0031706498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031706498&partnerID=8YFLogxK

M3 - Article

C2 - 9758312

AN - SCOPUS:0031706498

VL - 18

SP - 1011

EP - 1023

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 5

ER -